STERIX LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16239
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7155
 
  
 
C07J STEROIDS514
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8846737 CompoundAug 23, 10Sep 30, 14[C07D]
8148415 Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activityNov 22, 06Apr 03, 12[A61K, C07D]
8119627 Heterocyclic compounds as inhibitors of 17beta-HSD3Jan 02, 08Feb 21, 12[A61K]
8093279 CompoundSep 08, 09Jan 10, 12[A61K, C07D]
8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphataseMar 03, 06Oct 04, 11[A61K, C07J]
8022224 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumorsJun 13, 08Sep 20, 11[C07D]
7763642 Phenyl-sulfamates as aromatase inhibitorsDec 04, 06Jul 27, 10[A61K, C07D]
7244762 Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamatesFeb 19, 04Jul 17, 07[C07J]
7119081 Oestrogen-17-sulphamates as inhibitors of steroid sulphataseFeb 14, 03Oct 10, 06[A01N]
7067683 Industrially applicable process for the sulfamoylation of alcohols and phenolsDec 23, 02Jun 27, 06[C07J]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8492570 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor actionExpiredSep 22, 08Jul 23, 13[C07J]
8470860 Phenyl-sulfamates as aromatase inhibitorsExpiredJul 22, 10Jun 25, 13[A61K, C07D]
8394825 CompoundExpiredMar 27, 08Mar 12, 13[A61K, C07D]
8207152 Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cyclingExpiredOct 05, 05Jun 26, 12[A61K, A01N]
2012/0041,207 CompoundAbandonedAug 10, 11Feb 16, 12[C07D]
8026229 Antitumor-active 2-alkoxyestradiol sulfamatesExpiredAug 13, 02Sep 27, 11[A61K, C07J]
8003783 17B-hydroxysteroid dehydrogenase inhibitorsExpiredSep 23, 05Aug 23, 11[A61K, C07J]
2011/0112,151 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASEAbandonedFeb 25, 09May 12, 11[A61K, C07D, A61P]
7893284 Oestrogen derivatives as inhibitors of steroid sulphataseExpiredSep 23, 05Feb 22, 11[C07J]
RE42132 Antitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamatesExpiredFeb 19, 04Feb 08, 11[A61K, A61P, C07J]
2011/0009,448 CompoundAbandonedJul 23, 10Jan 13, 11[A61K, C12Q, C07D, A61P]
7846965 CompoundExpiredFeb 26, 07Dec 07, 10[A61K, C07D]
7786152 CompoundExpiredOct 31, 07Aug 31, 10[A61K]
2010/0197,647 COMPOUNDS THAT INHIBIT OESTRONE SULPHATASE; COMPOSITIONS THEREOF; AND METHODS EMPLOYING THE SAMEAbandonedDec 01, 09Aug 05, 10[A61K, A61P, C07J]
2010/0144,652 COMPOSITION COMPRISING A GLYCOLYTIC INHIBITOR AND A RING SYSTEM COMPRISING A SULPHAMATE GROUP FOR THE TREATMENT OF CANCERAbandonedFeb 07, 08Jun 10, 10[A61K, A61P]
2010/0120,789 CompoundAbandonedSep 07, 09May 13, 10[A61K, C12Q, C07D, C07C]
2010/0105,764 USEAbandonedJun 01, 09Apr 29, 10[A61K, A61P]
2009/0186,900 COMPOUNDAbandonedAug 27, 08Jul 23, 09[A61K, C07D, C07C]
2009/0042,929 11-Beta-Hydroxysteroid Dehydrogenase InhibitorsAbandonedMar 23, 06Feb 12, 09[A61K, C12Q, C07D, C07C, A61P]
7427610 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour actionExpiredFeb 19, 04Sep 23, 08[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.